The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis

Hepatology

Volumn 29, Issue 6, 1999, Pages 1643-1648

  Kim, W R ^a   Poterucha, J J ^a   Wiesner, R H ^a   LaRusso, N F ^a   Lindor, K D ^a   Petz, J ^a   Therneau, T M ^a   Malinchoc, M ^a   Dickson, E R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCLEROSING CHOLANGITIS; SCORING SYSTEM;

EID: 0033061541     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290607     Document Type: Article

References (22)

1. 1 Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Hunter EB, et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989 ; 10: 430–436. MEDLINE
2. 2 Farrant JM, Hayllar KM, Wilkinson M, Karani J, Portmann B, Westaby D, Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991 ; 100: 1710–1717. MEDLINE
3. 3 Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992 ; 103: 1893–1901. MEDLINE
4. 4 Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996 ; 38: 610–615. MEDLINE
5. 5 Kim WR, Lindor KD, Poterucha JJ, Benson JT, Therneau TM, Dickson ER. The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis [Abstract]. Gastroenterology 1998 ; 114: A1274.
6. 6 Lindor KD. Urosodiol for primary sclerosing cholangitis. N Engl J Med 1997 ; 336: 691–695. MEDLINE
7. 7 Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. 2 Surgery 1995 ; 117: 146–155. MEDLINE
8. 8 Ahrendt SA, Pitt HA, Kalloo AN, Venbrux AC, Klein AS, Herlong HF, Coleman J, et al. Primary sclerosing cholangitis: resect, dilate, or transplant? 3 Ann Surg 1998 ; 227: 412–423. MEDLINE
9. 9 Shetty K, Rybicki L, Carey WD. The Child‐Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997 ; 25: 1049–1053. MEDLINE
10. 10 LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Current concepts. Primary sclerosing cholangitis. 14 N Engl J Med 1984 ; 310: 899–903. MEDLINE
11. 11 Pugh RN, Murray‐Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. 8 Br J Surg 1973 ; 60: 646–649. MEDLINE
12. 12 Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transplant Surg 1997 ; 3: 628–637.
13. 13 Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia: Saunders, 628–637.
14. 14 Wantz GE, Payne MA. Experience with portacaval shunt for portal hypertension. N Engl J Med. 1961 ; 265: 721–728.
15. 15 Conn HO. A peek at the Child‐Turcotte classification. 6 Hepatology 1981 ; 1: 673–676. MEDLINE
16. 16 Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, Poulsen H, et al. Prognostic value of Child‐Turcotte criteria in medically treated cirrhosis. 3 Hepatology 1984 ; 4: 430–435. MEDLINE
17. 17 Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W. Prognosis and life expectancy in chronic liver disease. 8 Dig Dis Sci 1995 ; 40: 1805–1815. MEDLINE
18. 18 Siegel JH, Williams JB. A computer based index for the prediction of operative survival in patients with cirrhosis and portal hypertension. 2 Ann Surg 1969 ; 169: 191–201. MEDLINE
19. 19 Milani A, Marra L, Siciliano M, Rossi L. Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multivariate statistical approach. 6 Hepatogastroenterology 1985 ; 32: 270–272. MEDLINE
20. 20 Adler M, Verset D, Bouhdid H, Bourgeois N, Gulbis B, Le Moine O, Van de Stadt J, et al. Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score. 3 J Hepatol 1997 ; 26: 642–649. MEDLINE
21. 21 Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? 6 Hepatology 1996 ; 24: 1392–1394. MEDLINE
22. 22 Schluchter MD. Methods for the analysis of informatively censored longitudinal data. Statistics in Medicine 1992 ; 11: 1861–1870. MEDLINE